Keywords: HMGB1 DAMP Alarmin TLR4 Pain RAGE Dorsal root ganglia DRG a b s t r a c t Recent studies indicate that the release of high mobility group box 1 (HMGB1) following nerve injury may play a central role in the pathogenesis of neuropathic pain. HMGB1 is known to influence cellular responses within the nervous system via two distinct receptor families; the Receptor for Advanced Glycation End-products (RAGE) and Toll-like receptors (TLRs). The degree to which HMGB1 activates a receptor is thought to be dependent upon the oxidative state of the ligand, resulting in the functional isoforms of all-thiol HMGB1 (at-HMGB1) acting through RAGE, and disufide HMGB1 (ds-HMGB1) interacting with TLR4. Though it is known that dorsal root ganglia (DRG) sensory neurons exposed to HMGB1 and TLR4 agonists can influence excitation, the degree to which at-HMGB1 signaling through neuronal RAGE contributes to neuropathic pain is unknown. Here we demonstrate that at-HMGB1 activation of nociceptive neurons is dependent on RAGE and not TLR4. To distinguish the possible role of RAGE on neuropathic pain, we characterized the changes in RAGE mRNA expression up to one month after tibial nerve injury (TNI). RAGE mRNA expression in lumbar dorsal root ganglion (DRG) is substantially increased by postinjury day (PID) 28 when compared with sham injured rodents. Protein expression at PID28 confirms this injury-induced event in the DRG. Moreover, a single exposure to monoclonal antibody to RAGE (RAGE Ab) failed to abrogate pain behavior at PID 7, 14 and 21. However, RAGE Ab administration produced reversal of mechanical hyperalgesia on PID28. Thus, at-HMGB1 activation through RAGE may be responsible for sensory neuron sensitization and mechanical hyperalgesia associated with chronic neuropathic pain states.
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Introduction
Recent studies indicate inflammatory mediators released by nerve injury play a central role in the pathogenesis of chronic pain conditions (Calvo et al., 2012) . Although poorly understood, a key feature of these inflammatory events is the presence of Danger Associated Molecular Patterns (DAMPs; alarmins) Bianchi, 2007. A DAMP of particular interest to the injured nervous system is high mobility group protein box-1 (HMGB1; previously known as amphoterin) (Andersson and Tracey, 2011) . HMGB1, a nuclear protein that binds DNA and regulates gene expression is structurally composed of two tandem DNA-binding domains, Box A and B, and a highly acidic C-terminal tail composed of a string of aspartate and glutamate residues (Bianchi et al., 1992; Czura et al., 2001; Dumitriu et al., 2005; Giese et al., 1992) . Originally described as a membrane-associated protein which regulates neurite outgrowth during development, it is now known that HMGB1 also plays a crucial role in the inflammatory responses associated with tissue injury, reparative responses and disease (Parkkinen et al., 1993; Hori et al., 1995; Ulloa and Tracey, 2005; Maroso et al., 2010; Zhang et al., 2011) and may contribute significantly to chronic neuropathic pain states (Feldman et al., 2012; Shibasaki et al., 2010 
